You are here » Home » Companies » Company Overview » Wanbury Ltd

Wanbury Ltd.

BSE: 524212 Sector: Health care
NSE: WANBURY ISIN Code: INE107F01022
BSE 00:00 | 02 Dec 50.10 -0.75
(-1.47%)
OPEN

50.75

HIGH

51.35

LOW

50.10

NSE 00:00 | 02 Dec 50.45 -0.15
(-0.30%)
OPEN

50.75

HIGH

51.55

LOW

50.25

OPEN 50.75
PREVIOUS CLOSE 50.85
VOLUME 20950
52-Week high 111.75
52-Week low 49.15
P/E
Mkt Cap.(Rs cr) 164
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 50.75
CLOSE 50.85
VOLUME 20950
52-Week high 111.75
52-Week low 49.15
P/E
Mkt Cap.(Rs cr) 164
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Wanbury Ltd. (WANBURY) - Company History

Wanbury Ltd is the fastest growing pharma company with a Compounded Annual Growth Rate(CAGR) of 68% over the last 6 years.The company has strong presence in domestic formulationsActive Pharmaceutical Ingredient(API) and Contract Research and manufacturing Services(CRAMS).The company also has its presence in Europe in formulations.Wanbury was incorporated as Pearl Distributors Pvt Ltd in 1990.It went public and was renamed as Pearl Organics Ltd in 1991.The company has established its first plant in the year 1992 in Tarapur for manufacturing APIs.In 1995Pearl Organics acquired plant of Brij Chemicals Pvt Ltd at Patalganga.In 1996the company has entered into a strategic alliance with Wyckoff Chemicals to manufacture its API in US.In 2007Pharmaceutical Products India Ltd was amalgamated with the company pursuant to the BIFR order.In the same year Doctor's Organics and Chemicals Ltd also came into the fold of Wanbury as this also merged with Wanbury.The company has entered into a strategic association with Bravo Healthcare Ltd and also incorporated Ningxia Wanbury Fine Chemicals Co Ltd to source raw materials from China.The company has opened its office in ZurichSwitzerland for its CRAMS business and incorporated Wanbury Global FZE in Middle East for carrying out its trading activities in the year 2008.

.